title: Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
abstract: The treatment of people affected by multiple sclerosis, particularly the relapsing forms of the disease, has been transformed by the availability of various therapeutic agents. This landmark progress is due to an enormous foundation of clinical research and, particularly, numerous phase II and III clinical trials. Although the research community has many reasons to take pride in this progress, a fundamental question remains about whether opportunities for additional research are being lost due to inadequate clinical trial data sharing.
authors.affiliation: National Multiple Sclerosis Society USA, New York, USA timothy.coetzee@nmss.org.
authors.forename: Timothy
authors.initials: T
authors.lastname: Coetzee
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D033181:Information Dissemination; D009103:Multiple Sclerosis / Q000628:therapy*
keywords: Clinical trial; data sharing; information sharing; multiple sclerosis; patient advocacy